Placebo for AZD5148, AZD5148
D8820C00003 PRISM
Phase 2 small_molecule active
Quick answer
Placebo for AZD5148, AZD5148 for Recurrence of Clostridioides difficile Infection is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Recurrence of Clostridioides difficile Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active